Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -2025/26 group results

May 13 (Reuters)- 
          Takara Bio Inc. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to         NEXT     
              Mar 31, 2026    Mar 31, 2025    Mar 31, 2027       YEAR       
                 LATEST         YEAR-AGO         COMPANY         COMPANY    
                 RESULTS         RESULTS        FORECAST       H1 FORECAST  
  Sales           40.32           45.04           44.00           19.90     
               (-10.5 pct)     (+3.5 pct)      (+9.1 pct)      (+5.9 pct)   
  Operating     loss 4.69          2.26         loss 2.70       loss 2.35   
                               (-24.6 pct)                                  
  Recurring     loss 4.99          2.59         loss 3.00       loss 2.50   
                               (-23.9 pct)                                  
  Net
  Net           loss 9.60          1.04         loss 6.40       loss 4.45   
                               (-29.6 pct)                                  
  EPS        loss 79.72 yen     8.65 yen     loss 53.15 yen  loss 36.96 yen 
  Ann Div          NIL          17.00 yen                                   
  -Q2 Div          NIL             NIL                                      
  -Q4 Div          NIL          17.00 yen                                   
  
  NOTE - Takara Bio Inc..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news